-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|April 1, 2001

The American Journal of Managed Care

April 2001
Volume 7
Issue 4

Indirect Cost of Ischemic Heart Disease to Employers

Author(s)Bruce Sherman, MD. Author Reply by Christine J. Guico-Pabia, MD, MBA, James F. Murray, PhD, Marc L. Berger, MD

Articles in this issue

about 25 years ago

Article

Cost-Sharing for Prescriptions of Sildenafil and Finasteride: A Case Study in Veteran Patients

about 25 years ago

Article

Effects of Compensation Method on Physician Behaviors

about 25 years ago

Article

Healthy Pregnancy Program in a National Managed Care Organization: Evaluation of Satisfaction and Health Behavior Outcomes

about 25 years ago

Article

Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and Cost

about 25 years ago

Article

The Effect of Nonsteroidal anti-inflammatory Drugs on the Use of Gastroprotective Medication in People with Arthritis

about 25 years ago

Article

Achieving Control of Diabetic Risk Factors in Primary Care Settings

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC original research policy

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

AJMC original research clinical

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

AJMC original research managerial

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

AJMC trends from the field

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS